- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 02:18 | Cathie Wood's ARK buys OpenAI Group stock, sells Veracyte shares | ||
| 02:18 | Goldwind 2025 slides: revenue surges 29% amid wind power boom | ||
| 01:54 | Lilly to acquire Centessa for OX2R sleep disorder drugs | ||
| 01:54 | Service Properties Trust prices $500M share offering at $1.20 | ||
| 01:30 | Algernon Health to rename as Grey Matters Health, consolidate shares | ||
| 00:54 | Evercore ISI reiterates CoreWeave stock rating on debt facility | ||
| 00:54 | Raymond James raises Royal Gold stock price target on business model strength | ||
| 00:42 | nCino Q4 FY2026 presentation: profitability surges as growth moderates | ||
| 00:42 | Stifel cuts FactSet stock price target to $248 on growth questions | ||
| 00:42 | Keefe Bruyette cuts W.R. Berkley stock price target on reserve concerns | ||
| 00:42 | Raymond James reiterates Strong Buy on Kalaris stock, $23 target | ||
| 00:18 | Jefferies reiterates Annexon Biosciences stock rating on M&A activity | ||
| 00:18 | Stifel reiterates CoreWeave stock Hold rating on debt facility news | ||
| 00:06 | Jefferies lowers Coca-Cola stock price target on cost pressures | ||
| Di | XBP Global Q4 2025 slides: margin gains mask revenue decline | ||
| Di | INLIF approves 1-for-16 reverse stock split effective April 6 | ||
| Di | nCino stock jumps on accelerated growth, Raymond James reiterates | ||
| Di | Jefferies reiterates Enanta Pharmaceuticals stock rating on patent case | ||
| Di | Jefferies reiterates Nike stock Buy rating, keeps $110 price target | ||
| Di | Workhorse Q4 2025 slides: revenue surges post-merger, losses widen | ||
| Di | Aqua Metals 2026 presentation: battery recycling tech targets China cost parity | ||
| Di | Banzai Q4 2025 slides: revenue surges 116%, acquisition strategy accelerates | ||
| Di | Ellington Credit closes $54M notes offering with partial exercise | ||
| Di | Mizuho cuts BitGo stock price target on softer crypto backdrop | ||
| Di | Clear Street reiterates Palisade Bio stock rating on trial data |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.